SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-009367
Filing Date
2021-02-16
Accepted
2021-02-16 11:16:57
Documents
1
Group Members
PONTIFAX 4 G.P., LIMITED PARTNERSHIPPONTIFAX MANAGEMENT IV, G.P. (2015) LTD.TOMER KARIV

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea135739-13ga2ran_logicbio.htm SC 13G/A 162975
  Complete submission text file 0001213900-21-009367.txt   164409
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G/A

Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90696 | Film No.: 21634329
SIC: 2836 Biological Products, (No Diagnostic Substances)